No Data
No Data
Shanghai Gentech (688596.SH): Director and senior management personnel Shi Kecheng plans to Shareholding no more than 0.5445 million shares.
On March 11, Gelonghui reported that Shanghai Gentech (688596.SH) announced that due to its own funding needs, the Director and senior management personnel, Shi Kecheng, plans to reduce shareholding by no more than 544,500 shares through centralized bidding and block trading, which amounts to no more than 0.1864% of the total shares of the company (calculated based on the total share capital of 292,079,669 shares as of February 28, 2025); senior management personnel Zhen Gongliang plans to reduce shareholding by no more than 363,000 shares through centralized bidding and block trading, which accounts for no more than the company's shares.
Shanghai Gentech (688596.SH): The application for issuing Convertible Bonds has obtained registration approval from the China Securities Regulatory Commission.
On March 6, Glonghui reported that Shanghai Gentech (688596.SH) announced that on March 6, 2025, it received the "Approval from the China Securities Regulatory Commission (hereinafter referred to as 'CSRC') on the Registration of Issuing Convertible Corporate Bonds by Shanghai Gentech Co., Ltd. to Unspecified Objects" (License No. [2025]342). The main content is as follows: 1. Approval of the company's application to issue convertible corporate bonds to unspecified objects. 2. The company must strictly implement this issuance in accordance with the submitted declaration documents and issuance plan to the Shanghai Exchange. 3. This approval is effective from the date of agreement.
Zhengfan Technology: Shanghai Zhengfan Technology Co., Ltd. 2024 Annual Performance Report Announcement
Shanghai Zhengfan Technology Co., Ltd. 2024 Annual Results Express Announcement
Shanghai GenTech Co., Ltd.'s (SHSE:688596) Subdued P/E Might Signal An Opportunity
Zhengfan Technology: Voluntary Disclosure Notice of Shanghai Zhengfan Technology Co., Ltd. on the 2024 Annual Results Forecast